Medicines Co. Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Medicines Co. in den nächsten Jahren?
Pro
?
A****************
?
W******* i* V********
?
U****************
Kontra
?
L*********** I********** f** d** n******* J****
?
M************
?
M****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Medicines Co. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Medicines Co. | - | - | - | - | - | - | - |
| Opko Health Inc. | -2,54 % | 12,75 % | -12,21 % | 8,35 % | 5,49 % | -29,56 % | -60,98 % |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | -0,58 % | -1,15 % | 8,18 % | -14,00 % | -12,24 % | -36,30 % | -21,82 % |
| China Traditional Chinese Medicine Co Ltd | - | 0,00 % | 0,00 % | -9,84 % | 0,92 % | -46,60 % | -56,00 % |
Kommentare
News
Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock
Shares of biotechnology company Revolution Medicines (NASDAQ: RVMD) have surged more than 134% so far this year. Billionaire investor Stanley Druckenmiller's Duquesne Family Office drew attention to
Amneal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Amneal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amneal reported strong Q2 results, with revenue up 10% to $796 million, adjusted EBITDA up 12% to
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
Shares of Revolution Medicines (NASDAQ: RVMD), a clinical-stage drugmaker, have gained 132% this year, easily outpacing the returns of leading pharmaceutical companies such as Eli Lilly (NYSE: LLY)